United States · FDA National Drug Code directory
Pyridostigmine Bromide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58657-811_4aa4cfc7-d427-5306-e063-6394a90a628d
- Product NDC
- 58657-811
- Form
- TABLET
- Composition / generic term
- PYRIDOSTIGMINE BROMIDE
- Labeler
- Method Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240615
- Source listing expiry
- 20271231
Source-listed ingredients
- PYRIDOSTIGMINE BROMIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (58657-811-01) · 58657-811-01
- 30 TABLET in 1 BOTTLE (58657-811-30) · 58657-811-30
- 90 TABLET in 1 BOTTLE (58657-811-90) · 58657-811-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →